✦ LIBER ✦

Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients

✍ Scribed by Cooper, Ryan D.; Wiebe, Natasha; Smith, Nathaniel; Keiser, Philip; Naicker, Saraladevi; Tonelli, Marcello

Book ID: 126236986
Publisher: University of Chicago Press
Year: 2010
Tongue: English
Weight: 531 KB
Volume: 51
Category: Article
ISSN: 1058-4838
DOI: 10.1086/655681

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Renal Safety of Tenofovir Diso

Long-Term Renal Safety of Tenofovir Disoproxil Fumarate in Vertically HIV-Infected Children, Adolescents and Young Adults

✍ Dr Alessandra Viganò, Giorgio Bedogni, Valeria Manfredini, Vania Giacomet, Chiar 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 139 KB

Anti-hepatitis B virus efficacy of tenof

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

✍ Yves Benhamou; Herve Fleury; Pascale Trimoulet; Isabelle Pellegrin; Renaud Urbin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

for the TECOVIR Study Group Tenofovir disoproxil fumarate (TDF) has shown in vitro activity against both HIV and hepatitis B virus (HBV). We retrospectively evaluated the efficacy of TDF (300 mg/d), administered as a part of anti-retroviral therapy, in a large cohort of HIV/HBV-coinfected patients.

Safety and immunogenicity of measles vac

Safety and immunogenicity of measles vaccine in HIV-infected children: Systematic review and meta-analysis

✍ P. Scott; W.J. Moss; Z. Gilani; N. Low 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 84 KB

1155 Efficacy of tenofovir disoproxil fu

1155 Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients

✍ BENHAMOU, Y; PIKETTY, C; KATLAMA, C; ROZEMBAUM, W; NEAU, D; LAFEUILLADE, A; REY, 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

Evaluation of hypophosphataemia in tenof

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy

✍ K Buchacz; JT Brooks; T Tong; AC Moorman; RK Baker; SD Holmberg; A Greenberg; th 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

1028 RENAL SAFETY AND ANTIVIRAL EFFICACY

1028 RENAL SAFETY AND ANTIVIRAL EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) MONOTHERAPY IN NUCLEOS(T)IDE ANALOGUE REFRACTORY PATIENTS WITH HEPATITIS B VIRUS (HBV) MONO-INFECTION

✍ van Bömmel, F.; De Man, R.A.; Ferenci, P.; Reijnders, J.G.; Bronowicki, J.-P.; W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB